A 0 1 0 1 O
history 2 9 2 9 O
of 10 12 10 12 O
retinal 13 20 13 20 B-chronic_disease
vein 21 25 21 25 I-chronic_disease
occlusion 26 35 26 35 I-chronic_disease
( 36 37 36 37 I-chronic_disease
RVO 37 40 37 40 I-chronic_disease
) 40 41 40 41 I-chronic_disease
or 42 44 42 44 O
risks 45 50 45 50 O
factors 51 58 51 58 O
for 59 62 59 62 O
RVO 63 66 63 66 O

Absolute 0 8 67 75 B-clinical_variable
neutrophil 9 19 76 86 I-clinical_variable
count 20 25 87 92 I-clinical_variable
> 26 27 93 94 O
1,500 28 33 95 100 B-lower_bound
/ 33 34 100 101 I-lower_bound
uL 34 36 101 103 I-lower_bound
during 37 43 104 110 O
screening 44 53 111 120 O
evaluation 54 64 121 131 O

Any 0 3 132 135 O
major 4 9 136 141 B-treatment
surgery 10 17 142 149 I-treatment
, 17 18 149 150 O
extensive 19 28 151 160 B-treatment
radiotherapy 29 41 161 173 I-treatment
, 41 42 173 174 O
chemotherapy 43 55 175 187 B-treatment
with 56 60 188 192 I-treatment
delayed 61 68 193 200 I-treatment
toxicity 69 77 201 209 I-treatment
, 77 78 209 210 O
biologic 79 87 211 219 B-treatment
therapy 88 95 220 227 I-treatment
, 95 96 227 228 O
or 97 99 229 231 O
immunotherapy 100 113 232 245 B-treatment
within 114 120 246 252 O
30 121 123 253 255 B-upper_bound
days 124 128 256 260 I-upper_bound
of 129 131 261 263 O
enrollment 132 142 264 274 O
and/or 143 149 275 281 O
daily 150 155 282 287 O
or 156 158 288 290 O
weekly 159 165 291 297 O
chemotherapy 166 178 298 310 O
without 179 186 311 318 O
the 187 190 319 322 O
potential 191 200 323 332 O
for 201 204 333 336 O
delayed 205 212 337 344 O
toxicity 213 221 345 353 O
within 222 228 354 360 O
14 229 231 361 363 B-upper_bound
days 232 236 364 368 I-upper_bound
of 237 239 369 371 O
enrollment 240 250 372 382 O

Aspartate 0 9 383 392 B-clinical_variable
aminotransferase 10 26 393 409 I-clinical_variable
( 27 28 410 411 I-clinical_variable
AST 28 31 411 414 I-clinical_variable
) 31 32 414 415 I-clinical_variable
within 33 39 416 422 O
the 40 43 423 426 O
reference 44 53 427 436 O
range 54 59 437 442 O
during 60 66 443 449 O
screening 67 76 450 459 O
evaluation 77 87 460 470 O

Clinically 0 10 471 481 O
significant 11 22 482 493 O
cardiovascular 23 37 494 508 B-chronic_disease
disease 38 45 509 516 I-chronic_disease

Creatinine 0 10 517 527 B-clinical_variable
< 11 12 528 529 O
( 13 14 530 531 O
1.5 14 17 531 534 B-lower_bound
mg 18 20 535 537 I-upper_bound
/ 20 21 537 538 I-upper_bound
dL 21 23 538 540 I-upper_bound
) 23 24 540 541 O
during 25 31 542 548 O
screening 32 41 549 558 O
evaluation 42 52 559 569 O
( 53 54 570 571 O
> 54 55 571 572 O
1.5 56 59 573 576 O
is 60 62 577 579 O
allowed 63 70 580 587 O
if 71 73 588 590 O
epidermal 74 83 591 600 B-clinical_variable
growth 84 90 601 607 I-clinical_variable
factor 91 97 608 614 I-clinical_variable
receptor 98 106 615 623 I-clinical_variable
[ 107 108 624 625 I-clinical_variable
EGFR 108 112 625 629 I-clinical_variable
] 112 113 629 630 I-clinical_variable
> 114 115 631 632 O
45 116 118 633 635 B-lower_bound
mL 119 121 636 638 I-lower_bound
/ 121 122 638 639 I-lower_bound
min/1.73 122 130 639 647 I-lower_bound
m^2 131 134 648 651 I-lower_bound
) 134 135 651 652 O

Eastern 0 7 653 660 B-clinical_variable
Cooperative 8 19 661 672 I-clinical_variable
Oncology 20 28 673 681 I-clinical_variable
Group 29 34 682 687 I-clinical_variable
( 35 36 688 689 I-clinical_variable
ECOG 36 40 689 693 I-clinical_variable
) 40 41 693 694 I-clinical_variable
performance 42 53 695 706 I-clinical_variable
status 54 60 707 713 I-clinical_variable
of 61 63 714 716 O
0 64 65 717 718 B-lower_bound
- 65 66 718 719 O
2 66 67 719 720 B-upper_bound

Electrocardiogram 0 17 721 738 B-clinical_variable
( 18 19 739 740 I-clinical_variable
EKG 19 22 740 743 I-clinical_variable
) 22 23 743 744 I-clinical_variable
without 24 31 745 752 O
clinically 32 42 753 763 O
significant 43 54 764 775 O
abnormality 55 66 776 787 O

Gastrointestinal 0 16 788 804 B-chronic_disease
disorder 17 25 805 813 I-chronic_disease
affecting 26 35 814 823 O
absorption 36 46 824 834 O
( 47 48 835 836 O
e.g. 48 52 836 840 O
, 52 53 840 841 O
gastrectomy 54 65 842 853 B-chronic_disease
, 65 66 853 854 O
active 67 73 855 861 B-chronic_disease
peptic 74 80 862 868 I-chronic_disease
ulcer 81 86 869 874 I-chronic_disease
disease 87 94 875 882 I-chronic_disease
within 95 101 883 889 O
last 102 106 890 894 B-upper_bound
3 107 108 895 896 I-upper_bound
months 109 115 897 903 I-upper_bound
, 115 116 903 904 O
inflammatory 117 129 905 917 B-chronic_disease
bowel 130 135 918 923 I-chronic_disease
disease 136 143 924 931 I-chronic_disease
) 143 144 931 932 O

Hemoglobin 0 10 933 943 B-clinical_variable
> 11 12 944 945 O
9 13 14 946 947 B-lower_bound
g 15 16 948 949 I-lower_bound
/ 16 17 949 950 I-lower_bound
dL 17 19 950 952 I-lower_bound
during 20 26 953 959 O
screening 27 36 960 969 O
evaluation 37 47 970 980 O

Histologically 0 14 981 995 O
confirmed 15 24 996 1005 O
prostate 25 33 1006 1014 B-cancer
cancer 34 40 1015 1021 I-cancer
( 41 42 1022 1023 O
not 42 45 1023 1026 O
exclusive 46 55 1027 1036 O
of 56 58 1037 1039 O
adenocarcinoma 59 73 1040 1054 B-cancer
) 73 74 1054 1055 O

History 0 7 1056 1063 O
of 8 10 1064 1066 O
another 11 18 1067 1074 O
malignancy 19 29 1075 1085 B-cancer
within 30 36 1086 1092 O
the 37 40 1093 1096 O
previous 41 49 1097 1105 B-upper_bound
5 50 51 1106 1107 I-upper_bound
years 52 57 1108 1113 I-upper_bound
other 58 63 1114 1119 O
than 64 68 1120 1124 O
curatively 69 79 1125 1135 O
treated 80 87 1136 1143 O
non 88 91 1144 1147 B-cancer
- 91 92 1147 1148 I-cancer
melanoma 92 100 1148 1156 I-cancer
skin 101 105 1157 1161 I-cancer
cancer 106 112 1162 1168 I-cancer

History 0 7 1169 1176 O
of 8 10 1177 1179 O
clinically 11 21 1180 1190 O
significant 22 33 1191 1202 O
ventricular 34 45 1203 1214 B-chronic_disease
arrhythmias 46 57 1215 1226 I-chronic_disease
( 58 59 1227 1228 O
e.g. 59 63 1228 1232 O
, 63 64 1232 1233 O
ventricular 65 76 1234 1245 B-chronic_disease
tachycardia 77 88 1246 1257 I-chronic_disease
, 88 89 1257 1258 O
ventricular 90 101 1259 1270 B-chronic_disease
fibrillation 102 114 1271 1283 I-chronic_disease
, 114 115 1283 1284 O
torsades 116 124 1285 1293 B-chronic_disease
de 125 127 1294 1296 I-chronic_disease
pointes 128 135 1297 1304 I-chronic_disease
) 135 136 1304 1305 O

History 0 7 1306 1313 O
of 8 10 1314 1316 O
interstitial 11 23 1317 1329 B-chronic_disease
lung 24 28 1330 1334 I-chronic_disease
disease 29 36 1335 1342 I-chronic_disease
or 37 39 1343 1345 O
pneumonitis 40 51 1346 1357 B-chronic_disease

Hospitalization 0 15 1358 1373 O
within 16 22 1374 1380 O
30 23 25 1381 1383 B-upper_bound
days 26 30 1384 1388 I-upper_bound
of 31 33 1389 1391 O
enrollment 34 44 1392 1402 O
for 45 48 1403 1406 O
cancer 49 55 1407 1413 B-cancer
related 56 63 1414 1421 O
events 64 70 1422 1428 O

International 0 13 1429 1442 B-clinical_variable
normalized 14 24 1443 1453 I-clinical_variable
ratio 25 30 1454 1459 I-clinical_variable
( 31 32 1460 1461 I-clinical_variable
INR 32 35 1461 1464 I-clinical_variable
) 35 36 1464 1465 I-clinical_variable
< 37 38 1466 1467 O
1.3 39 42 1468 1471 B-upper_bound
( 43 44 1472 1473 O
or 44 46 1473 1475 O
< 47 48 1476 1477 O
3 49 50 1478 1479 O
if 51 53 1480 1482 O
on 54 56 1483 1485 O
warfarin 57 65 1486 1494 B-treatment
or 66 68 1495 1497 O
other 69 74 1498 1503 O
anticoagulants 75 89 1504 1518 B-treatment
) 89 90 1518 1519 O
during 91 97 1520 1526 O
screening 98 107 1527 1536 O
evaluation 108 118 1537 1547 O

Known 0 5 1548 1553 O
or 6 8 1554 1556 O
suspected 9 18 1557 1566 O
brain 19 24 1567 1572 B-cancer
metastasis 25 35 1573 1583 I-cancer
or 36 38 1584 1586 O
active 39 45 1587 1593 O
leptomeningeal 46 60 1594 1608 B-cancer
disease 61 68 1609 1616 I-cancer
or 69 71 1617 1619 O
spinal 72 78 1620 1626 B-chronic_disease
cord 79 83 1627 1631 I-chronic_disease
compression 84 95 1632 1643 I-chronic_disease

LVEF 0 4 1644 1648 B-clinical_variable
< 5 6 1649 1650 O
45 7 9 1651 1653 B-upper_bound
% 9 10 1653 1654 I-upper_bound
measured 11 19 1655 1663 O
by 20 22 1664 1666 O
echocardiogram 23 37 1667 1681 O

Left 0 4 1682 1686 B-clinical_variable
ventricular 5 16 1687 1698 I-clinical_variable
ejection 17 25 1699 1707 I-clinical_variable
fraction 26 34 1708 1716 I-clinical_variable
( 35 36 1717 1718 I-clinical_variable
LVEF 36 40 1718 1722 I-clinical_variable
) 40 41 1722 1723 I-clinical_variable
> 42 43 1724 1725 O
= 43 44 1725 1726 O
45 45 47 1727 1729 B-lower_bound
% 47 48 1729 1730 I-lower_bound
as 49 51 1731 1733 O
measured 52 60 1734 1742 O
by 61 63 1743 1745 O
echocardiogram 64 78 1746 1760 O
during 79 85 1761 1767 O
screening 86 95 1768 1777 O
evaluation 96 106 1778 1788 O

New 0 3 1789 1792 O
York 4 8 1793 1797 O
Heart 9 14 1798 1803 O
Association 15 26 1804 1815 O
( 27 28 1816 1817 O
NYHA 28 32 1817 1821 O
) 32 33 1821 1822 O
class 34 39 1823 1828 B-chronic_disease
III 40 43 1829 1832 I-chronic_disease
or 44 46 1833 1835 I-chronic_disease
IV 47 49 1836 1838 I-chronic_disease
congestive 50 60 1839 1849 I-chronic_disease
heart 61 66 1850 1855 I-chronic_disease
failure 67 74 1856 1863 I-chronic_disease

Patients 0 8 1864 1872 O
must 9 13 1873 1877 O
have 14 18 1878 1882 O
ongoing 19 26 1883 1890 O
therapy 27 34 1891 1898 O
to 35 37 1899 1901 O
maintain 38 46 1902 1910 O
serum 47 52 1911 1916 B-clinical_variable
testosterone 53 65 1917 1929 I-clinical_variable
< 66 67 1930 1931 O
50 68 70 1932 1934 B-upper_bound
ng 71 73 1935 1937 I-upper_bound
/ 73 74 1937 1938 I-upper_bound
dL 74 76 1938 1940 I-upper_bound

Presence 0 8 1941 1949 O
of 9 11 1950 1952 O
a 12 13 1953 1954 O
comorbid 14 22 1955 1963 B-chronic_disease
disease 23 30 1964 1971 I-chronic_disease
or 31 33 1972 1974 O
medical 34 41 1975 1982 O
condition 42 51 1983 1992 O
that 52 56 1993 1997 O
would 57 62 1998 2003 O
impair 63 69 2004 2010 O
the 70 73 2011 2014 O
ability 74 81 2015 2022 O
of 82 84 2023 2025 O
the 85 88 2026 2029 O
patient 89 96 2030 2037 O
to 97 99 2038 2040 O
receive 100 107 2041 2048 O
or 108 110 2049 2051 O
comply 111 117 2052 2058 O
with 118 122 2059 2063 O
the 123 126 2064 2067 O
study 127 132 2068 2073 O
protocol 133 141 2074 2082 O

Total 0 5 2083 2088 O
bilirubin 6 15 2089 2098 B-clinical_variable
within 16 22 2099 2105 O
the 23 26 2106 2109 O
reference 27 36 2110 2119 O
range 37 42 2120 2125 O
during 43 49 2126 2132 O
screening 50 59 2133 2142 O
evaluation 60 70 2143 2153 O

Uncontrolled 0 12 2154 2166 B-chronic_disease
angina 13 19 2167 2173 I-chronic_disease
within 20 26 2174 2180 O
3 27 28 2181 2182 B-upper_bound
months 29 35 2183 2189 I-upper_bound

Use 0 3 2190 2193 O
of 4 6 2194 2196 O
an 7 9 2197 2199 O
investigational 10 25 2200 2215 O
agent 26 31 2216 2221 O
within 32 38 2222 2228 O
4 39 40 2229 2230 B-upper_bound
weeks 41 46 2231 2236 I-upper_bound
of 47 49 2237 2239 O
enrollment 50 60 2240 2250 O

Use 0 3 2251 2254 O
of 4 6 2255 2257 O
any 7 10 2258 2261 O
medication 11 21 2262 2272 B-treatment
or 22 24 2273 2275 O
herbal 25 31 2276 2282 B-treatment
products 32 40 2283 2291 I-treatment
that 41 45 2292 2296 O
may 46 49 2297 2300 O
have 50 54 2301 2305 O
hormonal 55 63 2306 2314 O
anti 64 68 2315 2319 B-cancer
- 68 69 2319 2320 I-cancer
prostate 69 77 2320 2328 I-cancer
cancer 78 84 2329 2335 I-cancer
activity 85 93 2336 2344 O
and/or 94 100 2345 2351 O
are 101 104 2352 2355 O
known 105 110 2356 2361 O
to 111 113 2362 2364 O
modulate 114 122 2365 2373 O
PSA 123 126 2374 2377 O
levels 127 133 2378 2384 O
( 134 135 2385 2386 O
e.g. 135 139 2386 2390 O
, 139 140 2390 2391 O
saw 141 144 2392 2395 O
palmetto 145 153 2396 2404 O
) 153 154 2404 2405 O

Use 0 3 2406 2409 O
of 4 6 2410 2412 O
any 7 10 2413 2416 O
medications 11 22 2417 2428 O
known 23 28 2429 2434 O
to 29 31 2435 2437 O
affect 32 38 2438 2444 O
the 39 42 2445 2448 O
serum 43 48 2449 2454 B-clinical_variable
androgen 49 57 2455 2463 I-clinical_variable
level 58 63 2464 2469 I-clinical_variable

systemic 0 8 2470 2478 B-clinical_variable
corticosteroids 9 24 2479 2494 I-clinical_variable
greater 25 32 2495 2502 O
than 33 37 2503 2507 O
the 38 41 2508 2511 O
equivalent 42 52 2512 2522 O
of 53 55 2523 2525 O
10 56 58 2526 2528 B-lower_bound
mg 59 61 2529 2531 I-lower_bound
of 62 64 2532 2534 O
prednisone 65 75 2535 2545 B-treatment
per 76 79 2546 2549 O
day 80 83 2550 2553 O
within 84 90 2554 2560 O
4 91 92 2561 2562 B-upper_bound
weeks 93 98 2563 2568 I-upper_bound
of 99 101 2569 2571 O
enrollment 102 112 2572 2582 O

